ES2450998T3 - Nuevas variantes de proteína de cubierta E1 de rubéola y su utilización en la detección de anticuerpos anti-rubéola - Google Patents

Nuevas variantes de proteína de cubierta E1 de rubéola y su utilización en la detección de anticuerpos anti-rubéola

Info

Publication number
ES2450998T3
ES2450998T3 ES08860033.3T ES08860033T ES2450998T3 ES 2450998 T3 ES2450998 T3 ES 2450998T3 ES 08860033 T ES08860033 T ES 08860033T ES 2450998 T3 ES2450998 T3 ES 2450998T3
Authority
ES
Spain
Prior art keywords
rubella
antigen
disulfide
protein
chaperone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08860033.3T
Other languages
English (en)
Spanish (es)
Inventor
Christian Scholz
Ralf Bollhagen
Alfred Engel
Elke Faatz
Peter Schaarschmidt
Barbara Upmeier
Toralf Zarnt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2450998T3 publication Critical patent/ES2450998T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/19—Rubella virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES08860033.3T 2007-12-13 2008-12-11 Nuevas variantes de proteína de cubierta E1 de rubéola y su utilización en la detección de anticuerpos anti-rubéola Active ES2450998T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07024190 2007-12-13
EP07024190 2007-12-13
PCT/EP2008/010532 WO2009074318A2 (en) 2007-12-13 2008-12-11 Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies

Publications (1)

Publication Number Publication Date
ES2450998T3 true ES2450998T3 (es) 2014-03-26

Family

ID=40671057

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08860033.3T Active ES2450998T3 (es) 2007-12-13 2008-12-11 Nuevas variantes de proteína de cubierta E1 de rubéola y su utilización en la detección de anticuerpos anti-rubéola

Country Status (7)

Country Link
US (1) US8551696B2 (enExample)
EP (1) EP2222694B1 (enExample)
JP (1) JP5461423B2 (enExample)
CN (1) CN101939330B (enExample)
CA (1) CA2705716C (enExample)
ES (1) ES2450998T3 (enExample)
WO (1) WO2009074318A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2706115A1 (en) * 2012-09-06 2014-03-12 Roche Diagnostics GmbH Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays
CN104755499B (zh) * 2012-11-08 2020-10-02 霍夫曼-拉罗奇有限公司 结合HER3 β-发夹和HER4 β-发夹的抗HER3/HER4抗原结合蛋白
JP6695812B2 (ja) * 2014-05-14 2020-05-20 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト Ｈｅｒ３のベータヘアピン及びｈｅｒ２のドメインｉｉに結合するｈｅｒ３／ｈｅｒ２二重特異性抗体
WO2017055235A1 (en) * 2015-09-30 2017-04-06 Boehringer Ingelheim Vetmedica Gmbh Improved modular antigen transportation molecules and uses therof in animals
KR102943992B1 (ko) * 2015-12-15 2026-03-25 에프. 호프만-라 로슈 아게 트랜스글루타미나제 인식 부위를 갖는 fkbp 도메인
US12436148B2 (en) * 2018-07-02 2025-10-07 Siemens Healthcare Diagnostics Inc. Direct immunoassay measurement of autoantibodies
DE102019004812B4 (de) 2019-07-10 2021-03-18 Institut Virion-Serion GmbH Würzburg Rubella Virus Spike Konstrukt
CN115197941A (zh) * 2021-04-08 2022-10-18 中国科学院分子细胞科学卓越创新中心 具有分子伴侣功能的rna及其应用
CN116333164B (zh) * 2022-12-08 2026-07-21 青岛硕景生物科技有限公司 一种风疹病毒特异性融合蛋白抗原、其制备方法及检测试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001501093A (ja) 1996-09-26 2001-01-30 メディカル リサーチ カウンシル シャペロン断片
ES2378272T3 (es) * 1999-04-15 2012-04-10 Crucell Holland B.V. Producción de proteína recombinante en una célula humana
EP1103610A1 (en) * 1999-11-26 2001-05-30 Introgene B.V. Production of vaccines from immortalised mammalian cell lines
ATE522603T1 (de) 2001-06-22 2011-09-15 Hoffmann La Roche Löslicher komplex, der retrovirale oberflächen- glykoproteine und fkpa oder slyd enthält
US7604935B2 (en) * 2005-10-26 2009-10-20 Roche Diagnostics Operations, Inc. Soluble rubella E1 envelope protein variants
EP1780282B1 (en) * 2005-10-26 2010-12-08 Roche Diagnostics GmbH Recombinant expression of Rubella E1 envelope protein variants as chaperone fusion-proteins, and their use in the detection of anti-Rubella antibodies

Also Published As

Publication number Publication date
CN101939330B (zh) 2014-06-04
EP2222694B1 (en) 2014-01-15
CA2705716C (en) 2013-03-19
US20110059552A1 (en) 2011-03-10
US8551696B2 (en) 2013-10-08
WO2009074318A2 (en) 2009-06-18
HK1148026A1 (en) 2011-08-26
CN101939330A (zh) 2011-01-05
WO2009074318A3 (en) 2009-07-30
EP2222694A2 (en) 2010-09-01
JP5461423B2 (ja) 2014-04-02
JP2011505811A (ja) 2011-03-03
CA2705716A1 (en) 2009-06-18

Similar Documents

Publication Publication Date Title
KR100611545B1 (ko) 레트로바이러스 표면 당단백질을 함유하는 가용성 복합체
US8551696B2 (en) Rubella E1 envelope protein variants and their use in detection of anti-rubella antibodies
JP3945822B2 (ja) 複数エピトープ融合タンパク質
CA2667177C (en) Slpa as a tool for recombinant protein and enzyme technology
ES2561462T3 (es) Antígenos TpN47 de Treponema pallidum inmunorreactivos solubles
US20200033342A1 (en) Soluble and immunoreactive variants of htlv capsid antigen p24
US7074555B2 (en) Detection of West Nile Virus
EP1780282B1 (en) Recombinant expression of Rubella E1 envelope protein variants as chaperone fusion-proteins, and their use in the detection of anti-Rubella antibodies
ES2356383T3 (es) Expresión recombinante de variantes de proteína de cubierta de rubeola e1 como proteínas de fusión chaperonas, y utilización de las mismas en la detección de anticuerpos anti-rubeola.
JP7818525B2 (ja) 抗体－免疫アッセイでの使用のためのコロナヌクレオカプシド抗原
ES2949180T3 (es) Construcción de espícula del virus de la rubéola
HK1148026B (en) Novel rubella e1 envelope protein variants and their use in the detection of antirubella antibodies
AU2007200052B2 (en) A soluble complex comprising a retroviral surface glycoprotein
CN106699895A (zh) 一种新型融合抗原和包含其的检测试剂盒及应用